Candriam S.C.A. Ptc Therapeutics, Inc. Transaction History

Candriam S.C.A.

$18.4 Billion
Q3 2025

A detailed history of Candriam S.C.A. transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 146,265 shares of PTCT stock, worth $11 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

146,265

Previous 148,595 1.57%

Holding current value

$11 Million

Previous $7.26 Million 23.69%

% of portfolio

0.05%

Previous 0.04%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 05, 2025	SELL	$43.3 - $62.88 $100,889 - $146,510	-2,330 Reduced 1.57%	146,265 $8.98 Million
Q2 2025 Aug 08, 2025	SELL	$36.19 - $52.13 $380,139 - $547,573	-10,504 Reduced 6.6%	148,595 $7.26 Million
Q1 2025 May 14, 2025	SELL	$41.81 - $57.17 $42,228 - $57,741	-1,010 Reduced 0.63%	159,099 $8.11 Million
Q4 2024 Feb 06, 2025	SELL	$34.99 - $52.07 $283,803 - $422,339	-8,111 Reduced 4.82%	160,109 $7.23 Million
Q3 2024 Nov 13, 2024	BUY	$30.39 - $37.66 $5.11 Million - $6.34 Million	168,220 New	168,220 $6.24 Million

Q1 2024 May 03, 2024	SELL	$24.15 - $31.95 $3.01 Million - $3.98 Million	-124,604 Reduced 42.72%	167,048 $4.86 Million
Q2 2023 Aug 08, 2023	BUY	$40.4 - $59.1 $565,600 - $827,400	14,000 Added 5.04%	291,652 $11.9 Million
Q1 2023 May 12, 2023	BUY	$38.16 - $48.86 $2.86 Million - $3.66 Million	75,000 Added 37.01%	277,652 $13.4 Million
Q2 2022 Aug 03, 2022	SELL	$25.6 - $45.23 $1.81 Million - $3.2 Million	-70,722 Reduced 25.87%	202,652 $8.12 Million
Q2 2021 Jul 20, 2021	SELL	$37.95 - $49.37 $12.4 Million - $16.1 Million	-326,023 Reduced 54.39%	273,374 $11.6 Million
Q4 2020 Jan 22, 2021	SELL	$47.96 - $67.64 $7.22 Million - $10.2 Million	-150,563 Reduced 20.08%	599,397 $36.6 Million
Q3 2020 Oct 19, 2020	SELL	$45.41 - $57.07 $1.09 Million - $1.37 Million	-24,000 Reduced 3.1%	749,960 $35.1 Million
Q2 2020 Jul 23, 2020	BUY	$42.56 - $54.98 $7.32 Million - $9.45 Million	171,970 Added 28.57%	773,960 $39.3 Million
Q4 2019 Jan 21, 2020	SELL	$32.22 - $50.07 $2.85 Million - $4.43 Million	-88,533 Reduced 12.82%	601,990 $29,000
Q3 2019 Oct 21, 2019	BUY	$33.82 - $48.17 $1.69 Million - $2.41 Million	50,000 Added 7.81%	690,523 $23,000
Q2 2019 Aug 01, 2019	BUY	$35.42 - $45.0 $6.3 Million - $8.01 Million	178,000 Added 38.48%	640,523 $28.7 Million
Q1 2019 May 02, 2019	BUY	$28.09 - $39.49 $1.69 Million - $2.37 Million	60,000 Added 14.91%	462,523 $17.4 Million
Q4 2018 Feb 14, 2019	BUY	$29.83 - $46.51 $2.3 Million - $3.58 Million	77,000 Added 23.65%	402,523 $13.8 Million
Q3 2018 Nov 07, 2018	BUY	$33.9 - $47.77 $5.75 Million - $8.1 Million	169,523 Added 108.67%	325,523 $15.3 Million
Q2 2018 Aug 14, 2018	BUY	$25.7 - $47.88 $873,800 - $1.63 Million	34,000 Added 27.87%	156,000 $5.26 Million
Q1 2018 May 09, 2018	BUY	$17.46 - $32.59 $611,100 - $1.14 Million	35,000 Added 40.23%	122,000 $3.3 Million
Q4 2017 Feb 07, 2018	BUY	$15.14 - $20.89 $408,780 - $564,030	27,000 Added 45.0%	87,000 $1.45 Million
Q3 2017 Nov 03, 2017	BUY	$16.81 - $21.61 $1.01 Million - $1.3 Million	60,000	60,000 $1.2 Million

Others Institutions Holding PTCT

# of Institutions

325

Shares Held

83.2M

Call Options Held

811K

Put Options Held

207K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $5.39B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account